Skip to content
← Back to this collection

PUBLICATIONS · 25701171

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Mar
First author
Paz-Ares L

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Mar;16(3):246-7. doi: 10.1016/S1470-2045(15)70059-8.
    note
    Source null
    related pmid
    25701169
    relationship
    Comment in

Authors and identifiers

  1. name
    Paz-Ares L
    type
    Author
  2. name
    Mezger J
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Fischer JR
    type
    Author
  5. name
    von Pawel J
    type
    Author
  6. name
    Provencio M
    type
    Author
  7. name
    Kazarnowicz A
    type
    Author
  8. name
    Losonczy G
    type
    Author
  9. name
    de Castro G Jr
    type
    Author
  10. name
    Szczesna A
    type
    Author
  11. name
    Crino L
    type
    Author
  12. name
    Reck M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Paz-Ares L
    type
    Author
  2. name
    Mezger J
    type
    Author
  3. name
    Ciuleanu TE
    type
    Author
  4. name
    Fischer JR
    type
    Author
  5. name
    von Pawel J
    type
    Author
  6. name
    Provencio M
    type
    Author
  7. name
    Kazarnowicz A
    type
    Author
  8. name
    Losonczy G
    type
    Author
  9. name
    de Castro G Jr
    type
    Author
  10. name
    Szczesna A
    type
    Author
  11. name
    Crino L
    type
    Author
  12. name
    Reck M
    type
    Author
bibliography ids
  1. nci-bib-69cbc566939e202f7411afcf
book metadata
content sha256
469ba14111f377d601b2cb798fbd872481d0d9bdae4fe44186307990859b5ee4
document type
citation
dois
  1. 10.1016/S1470-2045(15)70046-X
electronic publication date
display
2015 Feb 18
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:25701171
immutable id
pubmed:25701171@469ba14111f377d601b2cb798fbd872481d0d9bdae4fe44186307990859b5ee4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
328-37
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Mar;16(3):246-7. doi: 10.1016/S1470-2045(15)70059-8.
    note
    Source null
    related pmid
    25701169
    relationship
    Comment in
outcomes validated
false
pmid
25701171
provenance
batch id
74265f1b641f04cf2d05
provider
NCBI PubMed ESummary
record sha256
b53c1e641dd599f727819a7f7cb249f86e73efe7783b3c55233716779beb12e7
response sha256
193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
retrieved at
2026-09-09T23:47:10.134322+00:00
publication date
display
2015 Mar
precision
month
year
2015
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/25701171/
title
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study.

Preserved source evidence · Not medical advice